Cronos Group (CRON) Competitors C$2.43 -0.02 (-0.82%) As of 04/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesBuy This Stock CRON vs. AUP, BHC, CARA, TEV, ABT, NOT, PYR, NVO, SLS, and DNAShould you be buying Cronos Group stock or one of its competitors? The main competitors of Cronos Group include Aurinia Pharmaceuticals (AUP), Bausch Health Companies (BHC), Cara Operations (CARA), Tervita (TEV), Absolute Software Co. (ABT.TO) (ABT), Noront Resources (NOT), PyroGenesis Canada Inc. (PYR.V) (PYR), Novo Resources Corp. (NVO.V) (NVO), Solaris Resources (SLS), and Dalradian Resources (DNA). These companies are all part of the "pharmaceutical products" industry. Cronos Group vs. Aurinia Pharmaceuticals Bausch Health Companies Cara Operations Tervita Absolute Software Co. (ABT.TO) Noront Resources PyroGenesis Canada Inc. (PYR.V) Novo Resources Corp. (NVO.V) Solaris Resources Dalradian Resources Cronos Group (TSE:CRON) and Aurinia Pharmaceuticals (TSE:AUP) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, community ranking, risk and analyst recommendations. Does the media refer more to CRON or AUP? In the previous week, Cronos Group had 2 more articles in the media than Aurinia Pharmaceuticals. MarketBeat recorded 2 mentions for Cronos Group and 0 mentions for Aurinia Pharmaceuticals. Cronos Group's average media sentiment score of 0.16 beat Aurinia Pharmaceuticals' score of 0.00 indicating that Cronos Group is being referred to more favorably in the media. Company Overall Sentiment Cronos Group Neutral Aurinia Pharmaceuticals Neutral Is CRON or AUP more profitable? Aurinia Pharmaceuticals has a net margin of 0.00% compared to Cronos Group's net margin of -42.65%. Aurinia Pharmaceuticals' return on equity of 0.00% beat Cronos Group's return on equity.Company Net Margins Return on Equity Return on Assets Cronos Group-42.65% -4.40% -3.73% Aurinia Pharmaceuticals N/A N/A N/A Which has better valuation and earnings, CRON or AUP? Cronos Group has higher revenue and earnings than Aurinia Pharmaceuticals. Cronos Group is trading at a lower price-to-earnings ratio than Aurinia Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCronos GroupC$76.86M8.35-C$32.78M-C$0.18-13.52Aurinia PharmaceuticalsC$57.59M0.00-C$190.03M-C$1.48N/A Do institutionals and insiders have more ownership in CRON or AUP? 16.0% of Cronos Group shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community prefer CRON or AUP? Aurinia Pharmaceuticals received 178 more outperform votes than Cronos Group when rated by MarketBeat users. Likewise, 72.22% of users gave Aurinia Pharmaceuticals an outperform vote while only 50.74% of users gave Cronos Group an outperform vote. CompanyUnderperformOutperformCronos GroupOutperform Votes6950.74% Underperform Votes6749.26% Aurinia PharmaceuticalsOutperform Votes24772.22% Underperform Votes9527.78% SummaryCronos Group beats Aurinia Pharmaceuticals on 7 of the 13 factors compared between the two stocks. Get Cronos Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRON vs. The Competition Export to ExcelMetricCronos GroupDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$641.68MC$2.13BC$5.31BC$5.53BDividend YieldN/A2.92%5.45%6.44%P/E Ratio-13.524.3321.9429.92Price / Sales8.35478.32380.94583.88Price / Cash1.6710.2538.2683.35Price / Book0.826.146.453.53Net Income-C$32.78MC$20.70BC$3.22BC$300.83M7 Day PerformanceN/A1.55%5.85%3.59%1 Month Performance-6.54%-3.00%-9.55%-3.87%1 Year Performance-25.00%93.87%11.83%11.28% Cronos Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRONCronos Group1.5414 of 5 starsC$2.43-0.8%C$3.54+45.7%-25.0%C$641.68MC$76.86M-13.52450News CoverageAUPAurinia PharmaceuticalsN/AN/AN/AN/AC$2.15BC$57.59M-11.32300High Trading VolumeBHCBausch Health CompaniesN/AC$6.32+5.2%N/A-40.8%C$1.64BC$6.69B-9.2519,900News CoverageCARACara OperationsN/AN/AN/AN/AC$1.62BN/A0.0080TEVTervitaN/AN/AN/AN/AC$672.00MC$1.36B-645.5636,800Gap UpABTAbsolute Software Co. (ABT.TO)N/AN/AN/AN/AC$636.46MC$104.67M63.42115,000High Trading VolumeNOTNoront ResourcesN/AC$1.10-0.5%N/A+0.0%C$612.18MN/A-7.20101,700PYRPyroGenesis Canada Inc. (PYR.V)N/AC$3.85+11.0%N/A+0.0%C$606.96MC$6.01M-154.0090Gap UpNVONovo Resources Corp. (NVO.V)N/AC$2.38-0.4%N/A+0.0%C$548.24MN/A-21.2554,400News CoverageSLSSolaris Resources1.3015 of 5 starsC$4.55flatC$13.90+205.5%+6.4%C$521.95MN/A-7.9310DNADalradian ResourcesN/AN/AN/AN/AC$519.02MN/A-56.15640 Related Companies and Tools Related Companies Aurinia Pharmaceuticals Alternatives Bausch Health Companies Alternatives Cara Operations Alternatives Tervita Alternatives Absolute Software Co. (ABT.TO) Alternatives Noront Resources Alternatives PyroGenesis Canada Inc. (PYR.V) Alternatives Novo Resources Corp. (NVO.V) Alternatives Solaris Resources Alternatives Dalradian Resources Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:CRON) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cronos Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
